Generated: August 23, 2017
DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 200565
, which is a drug marketed by Vistapharm, Wockhardt, Taro, Epic Pharma Llc, Mylan Pharms Inc, Actavis Mid Atlantic, Warner Chilcott, Marsam Pharms Llc, Fresenius Kabi Usa, West-ward Pharms Int, Aurobindo Pharma Ltd, Smith And Nephew, Solopak, Hospira, Watson Labs, Pharmeral, Acella Pharms Llc, and Luitpold, and is included in twenty-four NDAs. It is available from thirteen suppliers. Additional details are available on the PHENYTOIN profile page.
The generic ingredient in PHENYTOIN is phenytoin sodium. There are nineteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
Summary for NDA: 200565
|Formulation / Manufacturing:||see details|
Pharmacology for NDA: 200565
Complete Access Available with Subscription
Summary for product number 001
|Active Rx/OTC/Discontinued:||RX||Dosage:||TABLET, CHEWABLE;ORAL||Strength||50MG|
|Approval Date:||Apr 17, 2014||TE:||AB||RLD:||No|
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.